News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Optimi Health Appoints Chief Science Officer
Optimi Health
The Good Shroom Co Signs Retail Agency Agreement for the US Market
The Good Shroom Co
NeonMind Announces Creation of Medical Clinics Advisory Board to Guide Planning and Operation of Company-Branded Clinics Across Canada
NeonMind Biosciences Inc.
MindMed and Liechti Lab in Basel Switzerland Publish First Pharmacogenetic Data on LSD to Help Guide Personalized Dosing
Mind Medicine (MindMed)
Joseph Tucker | CEO, MagicMed Industries
Enveric Biosciences
Tryp Therapeutics Partners with Alcami for Proprietary Formulations
Tryp Therapeutics
PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig’s Disease
Pharmather
Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing Mushrooms
Mydecine Innovations Group
Jerry March | COO, New York Ketamine Infusions
Wellbeing Digital Sciences
MindMed Announces Launch of Collaboration with Nextage Therapeutics' Brain Targeting Liposome System
Mind Medicine (MindMed)
Enveric Biosciences Announces Definitive Agreement to Acquire MagicMed Industries
Enveric Biosciences
Douglas K. Gordon | CEO, Silo Wellness
Silo Wellness
Wesana Health Expands Research Leadership Team with Mark Wingertzahn, PhD as Chief Scientific Officer
Wesana Health
Braxia Scientific Announces Symbol Change on OTC markets to "BRAXF"
Braxia Scientific Corp.
Najla Guthrie | CEO & President, KGK Science
Wellbeing Digital Sciences
Dr. Rick Strassman | DMT Stroke Program Consultant, Algernon Pharmaceuticals
Algernon Pharmaceuticals
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.